The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.
 
John P. Neoptolemos
Consulting or Advisory Role - Boehringer Ingelheim; Kael-Gemvax; Novartis
Research Funding - AstraZeneca; Kael-Gemvax; Pharma Nord; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Nucana
 
Dan Palmer
Honoraria - Baxalta; Bayer; Boehringer Ingelheim
Consulting or Advisory Role - Baxalta; Bayer
Research Funding - Nucana
 
Paula Ghaneh
No Relationships to Disclose
 
Juan W. Valle
Honoraria - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Midatech Pharma; Novartis; Sirtex Medical
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Novartis; Sirtex Medical
Speakers' Bureau - Abbott Nutrition; Celgene; Ipsen; Novartis; Pfizer; Sirtex Medical
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
Jonathan Wadsley
Honoraria - AstraZeneca; Bayer; Celgene; Eisai; Novartis
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Eisai; Novartis
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Celgene; Novartis; SOBI
 
Tim Meyer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - Bayer; BTG; Ipsen
 
Alan Anthoney
No Relationships to Disclose
 
Bengt Glimelius
Consulting or Advisory Role - Isofol Medical; PledPharma
 
Stephen Falk
No Relationships to Disclose
 
Ralf Segersvard
Stock and Other Ownership Interests - Immunovia
 
Jakob R. Izbicki
No Relationships to Disclose
 
Gary William Middleton
Stock and Other Ownership Interests - Agenus
Consulting or Advisory Role - Boehringer Ingelheim; Lilly
Speakers' Bureau - Pierre Fabre; Roche
Research Funding - AstraZeneca; Kael-Gemvax
Travel, Accommodations, Expenses - MSD
 
Paul J. Ross
Honoraria - Bayer; Celgene; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Celgene; Roche; Sanofi; Sirtex Medical
Research Funding - Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene; Merck Serono; Sirtex Medical
 
Harpreet Wasan
Honoraria - Lilly
Travel, Accommodations, Expenses - Lilly
 
Alec Mcdonald
No Relationships to Disclose
 
Tom David Lewis Crosby
No Relationships to Disclose
 
Eftychia Eirini Psarelli
No Relationships to Disclose
 
Pascal Hammel
Consulting or Advisory Role - AstraZeneca; Celgene
Research Funding - Roche
Travel, Accommodations, Expenses - Merck Serono
 
Markus W. Buchler
No Relationships to Disclose